(Q45034864)

8 December 2017

Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome (English)

1 reference

8 December 2017

1 reference

Stanley R Pillemer

1

1 reference

8 December 2017

Michael T Brennan

2

1 reference

8 December 2017

Vidya Sankar

3

1 reference

8 December 2017

Rose Anne Leakan

4

1 reference

8 December 2017

Janine A Smith

5

1 reference

8 December 2017

Margaret Grisius

6

1 reference

8 December 2017

Sophie Ligier

7

1 reference

8 December 2017

Lida Radfar

8

1 reference

8 December 2017

Marc R Kok

9

1 reference

8 December 2017

Albert Kingman

10

1 reference

8 December 2017

Philip C Fox

11

1 reference

8 December 2017

1 August 2004

1 reference

8 December 2017

Arthritis & Rheumatology

1 reference

8 December 2017

51

1 reference

8 December 2017

4

1 reference

8 December 2017

601-604

1 reference

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus

8 December 2017

1 reference

Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Sjögren's syndrome. Proposed criteria for classification

21 January 2018

1 reference

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

Sex hormone adjuvant therapy in rheumatoid arthritis

21 January 2018

1 reference

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.20540

1 reference

8 December 2017

1 reference